TaylorRiall United States

• UPPER GI - ESOPHAGEAL CANCER WITH CLINICAL COMPLETE RESPONSE POST CHEMORADIATION
  EARLY ELECTIVE SURGERY
  216-1
  SherazMarkar Speaker United Kingdom
• UPPER GI - ESOPHAGEAL CANCER WITH CLINICAL COMPLETE RESPONSE POST CHEMORADIATION
  SURVEILLANCE AND DELAYED SURGERY
  216-2
  Simon Ying-Kit Law Speaker Hong Kong, China
• HPB – NEOADJUVANT CHEMOTHERAPY FOR RESECTABLE PANCREAS CANCER
  SURGERY + ADJUVANT THERAPY
  216-3
  Eduardo E. Montalvo Jave Speaker Mexico
• HPB – NEOADJUVANT CHEMOTHERAPY FOR RESECTABLE PANCREAS CANCER
  NEOADJUVANT THERAPY
  216-4
  TaylorRiall Speaker United States
• CRC – MANAGEMENT OF RECTAL CANCER WITH COMPLETE CLINICAL RESPONSE AFTER TOTAL NEOADJUVANT THERAPY (TNT) IN THE SETTING OF SYNCHRONOUS OLIGOMETASTATIC LIVER METASTASES — SHOULD THE RECTUM BE LEFT INTACT IF LIVER RESECTION IS PURSUED?
  YES - WHEN IN DOUBT, TAKE IT OUT!
  216-5
  AlessandroFichera Speaker United States
• CRC – MANAGEMENT OF RECTAL CANCER WITH COMPLETE CLINICAL RESPONSE AFTER TOTAL NEOADJUVANT THERAPY (TNT) IN THE SETTING OF SYNCHRONOUS OLIGOMETASTATIC LIVER METASTASES — SHOULD THE RECTUM BE LEFT INTACT IF LIVER RESECTION IS PURSUED?
  LEAVE IT ALONE - PRIMUM NON NOCERE
  216-6